2021
DOI: 10.1017/ice.2021.8
|View full text |Cite
|
Sign up to set email alerts
|

Lack of viable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) among PCR-positive air samples from hospital rooms and community isolation facilities

Abstract: Background: Understanding the extent of aerosol-based transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is important for tailoring interventions for control of the coronavirus disease 2019 (COVID-19) pandemic. Multiple studies have reported the detection of SARS-CoV-2 nucleic acid in air samples, but only one study has successfully recovered viable virus, although it is limited by its small sample size. Objective: We aimed to determine the extent of shedding of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
25
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
2
1

Relationship

1
8

Authors

Journals

citations
Cited by 32 publications
(27 citation statements)
references
References 26 publications
2
25
0
Order By: Relevance
“…Information regarding the size fractionations of particles in the aerosols were provided by data generated using the PCIS and NIOSH bioaerosol sampler, which showed the virus-associated particles were >0.25 μm and >0.1 μm respectively. This is consistent with the findings of previous studies on the collection of airborne SARS-CoV-2 in different settings ( Chia et al, 2020 ; Feng et al, 2021 ; Lednicky, Lauzardo, et al, 2021 ; Liu et al, 2020b ; Ong et al, 2021 ). In general, particles in the respirable size range, i.e., particles of size <4 μm can reach the alveoli upon inhalation ( Brown et al, 2013 ).…”
Section: Discussionsupporting
confidence: 93%
“…Information regarding the size fractionations of particles in the aerosols were provided by data generated using the PCIS and NIOSH bioaerosol sampler, which showed the virus-associated particles were >0.25 μm and >0.1 μm respectively. This is consistent with the findings of previous studies on the collection of airborne SARS-CoV-2 in different settings ( Chia et al, 2020 ; Feng et al, 2021 ; Lednicky, Lauzardo, et al, 2021 ; Liu et al, 2020b ; Ong et al, 2021 ). In general, particles in the respirable size range, i.e., particles of size <4 μm can reach the alveoli upon inhalation ( Brown et al, 2013 ).…”
Section: Discussionsupporting
confidence: 93%
“…While it has been previously shown that COVID-19 patients can emit infectious virus-laden aerosols into their environments [5,20], most environmental SARS-CoV-2 sampling studies have been unable to mechanically retrieve and isolate viable virus from ambient air in the vicinity of COVID-19 patients [21]. Hence, the infectious proportion of virus emitted from patient expiration remains unclear.…”
Section: Discussionmentioning
confidence: 99%
“…Our studies support reports of infectious SARS-CoV-2 collected from aerosols near COVID-19 patients [4][5][6][7], as well as studies showing non-contact transmission of SARS-CoV-2 between ferrets and hamsters [17,18,22], including one study that demonstrated transmission over a 1-meter distance [28]. Some previous studies have been unable to culture virus from air samples from COVID-19 patients or inoculated non-human primates due to unknown collection times post-onset of disease or the use of air sampling equipment or buffers that do not maintain viral infectivity [16,29]. Our results support the idea that transmission is likely to occur prior to or concurrent with symptom onset or in the absence of clinical disease, supporting studies that have found that asymptomatic infection is a major driver of community transmission [23,24].…”
Section: Discussionmentioning
confidence: 99%